tiprankstipranks

Scott Canute Insider Profile

4 Followers
Scott Canute, Director at Flexion Therapeutics, holds 0.00 shares in Immunomedics (Ticker: IMMU), holds 4.50K shares in Flexion Therapeutics (Ticker: FLXN), holds 13.70K shares in Akebia Therapeutics (Ticker: AKBA).
tipranks
Scott Canute

Scott Canute
Flexion Therapeutics (FLXN)
Director

Not Ranked
Scott Canute has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$7M
98.71%
0.66%
0.63%
0.00%
0.00% Others
A breakdown of Scott Canute's holdings

Insider Roles

Eli Lilly & Co
(LLY)
President, Mfg. Operations
Flexion Therapeutics
(FLXN)
Director
Akebia Therapeutics
(AKBA)
Director
Outlook Therapeutics
(OTLK)
Director
+1 other positions
Roles that Scott Canute holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Scott Canute

Scott Canute's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Flexion Therapeutics
Jun 12, 2020
Director
Uninformative Buy
$48.69K
Akebia Therapeutics
Jun 10, 2019
Director
Uninformative Buy
$46.44K
ONSIU
Oncobiologics Inc
Nov 30, 2016
Uninformative Buy
$891.77K
IMMU
Immunomedics
Oct 23, 2020
Uninformative Sell
$0.00
Outlook Therapeutics
Director
Protara Therapeutics
Director
$0.00
Eli Lilly & Co
President, Mfg. Operations
$7.28M
List of latest transactions for each holding click on a transaction to see Scott Canute's performance on stock

Scott Canute insider profile FAQ

What is the percentage of profitable transactions made by Scott Canute?
The percentage of profitable transactions made by Scott Canute is ―.
    What is the average return per transaction made by Scott Canute?
    The average return per transaction made by Scott Canute is ―.
      What stocks does Scott Canute hold?
      Scott Canute holds: FLXN, AKBA, ONSIU, IMMU, OTLK, TARA, LLY stocks.
        What was Scott Canute’s latest transaction?
        Scott Canute latest transaction was an Uninformative Sell of ―.
          What was Scott Canute's most profitable transaction?
          Scott Canute’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Scott Canute's role in Flexion Therapeutics?
            Scott Canute's role in Flexion Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.